The administration of anti-cancer agents, like the withanidolide Withaferin-A, has been demonstrated to cause the downregulation of XIAP, cIAP2 (BIRC3) and Survivin while inducing apoptosis of human breast cancer cells. This evidence concerns the gene BIRC3 and breast carcinoma.